Atlanta-based Sensiotec has received FDA 510(k) Class II clearance for its ultra-wideband (UWB) non-contact, continuous monitor for heart and respiration rates. The device, Preventa, will be marketed and sold in the U.S. and Canada.
According to the company, Preventa is the world's first medical device to harness UWB, a former classified military technology, to create a wireless vital signs monitor. The device monitors heart, respiration rates and movement, and also alerts caregivers when a patient requires relocation to help prevent bed sores. Because patients can be watched remotely, caregivers gain a disease management tool that can help reduce complications associated with common chronic illnesses such as heart disease, COPD and sleep apnea and reduce hospital admissions and ER visits.
Sensiotec CTO Efraim Gavrilovich states, "Wireless monitoring has great potential as an early warning system that helps to identify and manage health crises when they arise."